154 related articles for article (PubMed ID: 38574314)
1. Modern Multidisciplinary Management of Soft Tissue Sarcoma of the Extremity and Trunk.
Campbell SR; Wooley JR; Nystrom LM
JCO Oncol Pract; 2024 Apr; ():OP2300050. PubMed ID: 38574314
[TBL] [Abstract][Full Text] [Related]
2. Treating soft tissue sarcomas with adjuvant chemotherapy.
Patrikidou A; Domont J; Cioffi A; Le Cesne A
Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
[TBL] [Abstract][Full Text] [Related]
3. Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey.
Rothermundt C; Fischer GF; Bauer S; Blay JY; Grünwald V; Italiano A; Kasper B; Kollár A; Lindner LH; Miah A; Sleijfer S; Stacchiotti S; Putora PM
Oncologist; 2018 Apr; 23(4):461-467. PubMed ID: 29192019
[TBL] [Abstract][Full Text] [Related]
4. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D
Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656
[TBL] [Abstract][Full Text] [Related]
5. Trimodality Treatment of Extremity Soft Tissue Sarcoma: Where Do We Go Now?
Oberoi S; Choy E; Chen YL; Scharschmidt T; Weiss AR
Curr Treat Options Oncol; 2023 Apr; 24(4):300-326. PubMed ID: 36877374
[TBL] [Abstract][Full Text] [Related]
6. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
7. How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment.
Mazzocca A; Paternostro F; Minelli A; Silletta M; Greco C; Valeri S; Ramella S; Tonini G; Vincenzi B
Chemotherapy; 2022; 67(4):234-247. PubMed ID: 35728569
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy for extremity sarcomas.
Schlieman M; Smith R; Kraybill WG
Curr Treat Options Oncol; 2006 Nov; 7(6):456-63. PubMed ID: 17032558
[TBL] [Abstract][Full Text] [Related]
9. Effect of negative pressure wound therapy after surgical removal of deep-seated high-malignant soft tissue sarcomas of the extremities and trunk wall-study protocol for a randomized controlled trial.
Yilmaz M; Thorn A; Sørensen MS; Jensen CL; Petersen MM
Trials; 2022 Jun; 23(1):507. PubMed ID: 35717239
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.
Chung PW; Deheshi BM; Ferguson PC; Wunder JS; Griffin AM; Catton CN; Bell RS; White LM; Kandel RA; O'Sullivan B
Cancer; 2009 Jul; 115(14):3254-61. PubMed ID: 19472403
[TBL] [Abstract][Full Text] [Related]
11. Current stand on systemic therapy in localized soft tissue sarcomas: a clinician's perspective.
Sasi A; Rastogi S
Future Oncol; 2023 Oct; 19(31):2135-2145. PubMed ID: 37860850
[TBL] [Abstract][Full Text] [Related]
12. Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy.
Bedi M; King DM; Shivakoti M; Wang T; Zambrano EV; Charlson J; Hackbarth D; Neilson J; Whitfield R; Wang D
Radiat Oncol; 2013 Mar; 8():60. PubMed ID: 23497372
[TBL] [Abstract][Full Text] [Related]
13. New trends in the surgical management of soft tissue sarcoma: The role of preoperative biopsy.
Pavlidis ET; Pavlidis TE
World J Clin Oncol; 2023 Feb; 14(2):89-98. PubMed ID: 36908679
[TBL] [Abstract][Full Text] [Related]
14. What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?
Hindi N; Martin-Broto J
Curr Opin Oncol; 2021 Jul; 33(4):329-335. PubMed ID: 33973551
[TBL] [Abstract][Full Text] [Related]
15. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
16. The Effect of chemo- and radiotherapy on tumor necrosis in soft tissue sarcoma- does it influence prognosis?
Fromm J; Klein A; Kirilova M; Lindner LH; Nachbichler S; Holzapfel BM; Goller SS; Knösel T; Dürr HR
BMC Cancer; 2024 Mar; 24(1):303. PubMed ID: 38448852
[TBL] [Abstract][Full Text] [Related]
17. Local management of adult soft tissue sarcomas.
Swallow CJ; Catton CN
Semin Oncol; 2007 Jun; 34(3):256-69. PubMed ID: 17560988
[TBL] [Abstract][Full Text] [Related]
18. An Update on Non-extremity Soft Tissue Sarcomas.
Ford SJ; Almond LM; Gronchi A
Clin Oncol (R Coll Radiol); 2017 Aug; 29(8):516-527. PubMed ID: 28330704
[TBL] [Abstract][Full Text] [Related]
19. Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity?
Bedi M; Ethun CG; Charlson J; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Cardona K; King DM
Clin Orthop Relat Res; 2020 Mar; 478(3):550-559. PubMed ID: 32168066
[TBL] [Abstract][Full Text] [Related]
20. What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?
Chmiel P; Rutkowski P; Spałek M; Szumera-Ciećkiewicz A; Czarnecka AM
Curr Treat Options Oncol; 2024 May; ():. PubMed ID: 38809411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
